Skip to main content
Erschienen in: Cancer and Metastasis Reviews 1-2/2012

01.06.2012 | NON-THEMATIC REVIEW

Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms

verfasst von: Jingjing Quan, Newell W. Johnson, Guangbiao Zhou, Peter G. Parsons, Glen M. Boyle, Jin Gao

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 1-2/2012

Einloggen, um Zugang zu erhalten

Abstract

Bone invasion is a common characteristic of oral squamous cell carcinoma (OSCC), with adverse affects on patient functionality and survival. Recent studies suggest that it is osteoclasts, rather than malignant keratinocytes themselves, which play the major role in facilitating the entry of the tumour into bone, and its progression within bone. Osteoclasts respond to a variety of local signalling pathways, initiated by products of the malignant epithelial cells. In the present review, we firstly introduce the clinical patterns of bone invasion, and then summarise these signalling pathways and their diverse roles in sequential phases of bone invasion. We also review current researches regarding the incidence and mechanisms of distant metastases to bone, and explain briefly the concept of epithelial-mesenchymal transition, which may generate cancer stem cells and initiate the bone invasion. Finally, we discuss more briefly approaches to the diagnosis and management of OSCC patients with bone invasion. With all these studies and some recent discoveries in our own laboratory, an enhanced understanding of bone invasion will be achieved, which should indicate potential molecular targets for future biotherapies.
Literatur
1.
Zurück zum Zitat Warnakulasuriya, S. (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncology, 45(4–5), 309–316.PubMedCrossRef Warnakulasuriya, S. (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncology, 45(4–5), 309–316.PubMedCrossRef
2.
Zurück zum Zitat Johnson, N. W., Jayasekara, P., & Amarasinghe, A. A. H. K. (2011). Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontology 2000, 57(1), 19–37.PubMedCrossRef Johnson, N. W., Jayasekara, P., & Amarasinghe, A. A. H. K. (2011). Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontology 2000, 57(1), 19–37.PubMedCrossRef
3.
Zurück zum Zitat Johnson, N. W., Warnakulasuriya, S., Gupta, P. C., Dimba, E., Chindia, M., Otoh, E. C., et al. (2011). Global inequalities in incidence and outcomes for oral cancer: causes and solutions. Advances in Dental Research, 23(2), 237–246.PubMedCrossRef Johnson, N. W., Warnakulasuriya, S., Gupta, P. C., Dimba, E., Chindia, M., Otoh, E. C., et al. (2011). Global inequalities in incidence and outcomes for oral cancer: causes and solutions. Advances in Dental Research, 23(2), 237–246.PubMedCrossRef
4.
Zurück zum Zitat Chen, Y. L., Kuo, S. W., Fang, K. H., & Hao, S. P. (2011). Prognostic impact of marginal mandibulectomy in the presence of superficial bone invasion and the nononcologic outcome. Head & Neck, 33(5), 708–713.CrossRef Chen, Y. L., Kuo, S. W., Fang, K. H., & Hao, S. P. (2011). Prognostic impact of marginal mandibulectomy in the presence of superficial bone invasion and the nononcologic outcome. Head & Neck, 33(5), 708–713.CrossRef
5.
Zurück zum Zitat Lubek, J., El-Hakim, M., Salama, A. R., Liu, X., & Ord, R. A. (2011). Gingival carcinoma: retrospective analysis of 72 patients and indications for elective neck dissection. British Journal of Oral and Maxillofacial Surgery, 49(3), 182–185.PubMedCrossRef Lubek, J., El-Hakim, M., Salama, A. R., Liu, X., & Ord, R. A. (2011). Gingival carcinoma: retrospective analysis of 72 patients and indications for elective neck dissection. British Journal of Oral and Maxillofacial Surgery, 49(3), 182–185.PubMedCrossRef
6.
Zurück zum Zitat Hoffmannová, J., Foltán, R., Vlk, M., Sipos, M., Horká, E., Pavlíková, G., et al. (2010). Hemimandibulectomy and therapeutic neck dissection with radiotherapy in the treatment of oral squamous cell carcinoma involving mandible: a critical review of treatment protocol in the years 1994–2004. International Journal of Oral and Maxillofacial Surgery, 39(6), 561–567.PubMedCrossRef Hoffmannová, J., Foltán, R., Vlk, M., Sipos, M., Horká, E., Pavlíková, G., et al. (2010). Hemimandibulectomy and therapeutic neck dissection with radiotherapy in the treatment of oral squamous cell carcinoma involving mandible: a critical review of treatment protocol in the years 1994–2004. International Journal of Oral and Maxillofacial Surgery, 39(6), 561–567.PubMedCrossRef
7.
Zurück zum Zitat Pandey, M., Rao, L. P., Das, S. R., Mathews, A., Chacko, E. M., & Naik, B. R. (2007). Patterns of mandibular invasion in oral squamous cell carcinoma of the mandibular region. World Journal of Surgical Oncology, 30, 5–12. Pandey, M., Rao, L. P., Das, S. R., Mathews, A., Chacko, E. M., & Naik, B. R. (2007). Patterns of mandibular invasion in oral squamous cell carcinoma of the mandibular region. World Journal of Surgical Oncology, 30, 5–12.
8.
Zurück zum Zitat Brown, J. S., Lowe, D., Kalavrezos, N., D’Souza, J., Magennis, P., & Woolgar, J. (2002). Patterns of invasion and routes of tumor entry into the mandible by oral squamous cell carcinoma. Head & Neck, 24(4), 370–383.CrossRef Brown, J. S., Lowe, D., Kalavrezos, N., D’Souza, J., Magennis, P., & Woolgar, J. (2002). Patterns of invasion and routes of tumor entry into the mandible by oral squamous cell carcinoma. Head & Neck, 24(4), 370–383.CrossRef
9.
Zurück zum Zitat Shaw, R. J., Brown, J. S., Woolgar, J. A., Lowe, D., Rogers, S. N., & Vaughan, E. D. (2004). The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head & Neck, 26(10), 861–869.CrossRef Shaw, R. J., Brown, J. S., Woolgar, J. A., Lowe, D., Rogers, S. N., & Vaughan, E. D. (2004). The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head & Neck, 26(10), 861–869.CrossRef
10.
Zurück zum Zitat Brown, J. S., & Browne, R. M. (1995). Factors influencing the patterns of invasion of the mandible by oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, 24(6), 417–426.PubMedCrossRef Brown, J. S., & Browne, R. M. (1995). Factors influencing the patterns of invasion of the mandible by oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, 24(6), 417–426.PubMedCrossRef
11.
Zurück zum Zitat Ito, M., Izumi, N., Cheng, J., Sakai, H., Shingaki, S., Nakajima, T., et al. (2003). Jaw bone remodeling at the invasion front of gingival squamous cell carcinomas. Journal of Oral Pathology & Medicine, 32(1), 10–17.CrossRef Ito, M., Izumi, N., Cheng, J., Sakai, H., Shingaki, S., Nakajima, T., et al. (2003). Jaw bone remodeling at the invasion front of gingival squamous cell carcinomas. Journal of Oral Pathology & Medicine, 32(1), 10–17.CrossRef
12.
Zurück zum Zitat Goda, T., Shimo, T., Yoshihama, Y., Hassan, N. M., Ibaragi, S., Kurio, N., et al. (2010). Bone destruction by invading oral squamous carcinoma cells mediated by the transforming growth factor-beta signalling pathway. Anticancer Research, 30(7), 2615–2623.PubMed Goda, T., Shimo, T., Yoshihama, Y., Hassan, N. M., Ibaragi, S., Kurio, N., et al. (2010). Bone destruction by invading oral squamous carcinoma cells mediated by the transforming growth factor-beta signalling pathway. Anticancer Research, 30(7), 2615–2623.PubMed
13.
Zurück zum Zitat Ebrahimi, A., Murali, R., Gao, K., Elliott, M. S., & Clark, J. R. (2011). The prognostic and staging implications of bone invasion in oral squamous cell carcinoma. Cancer, 117(19), 4460–4467.PubMedCrossRef Ebrahimi, A., Murali, R., Gao, K., Elliott, M. S., & Clark, J. R. (2011). The prognostic and staging implications of bone invasion in oral squamous cell carcinoma. Cancer, 117(19), 4460–4467.PubMedCrossRef
14.
Zurück zum Zitat Wysluch, A., Stricker, I., Hölzle, F., Wolff, K. D., & Maurer, P. (2010). Intraoperative evaluation of bony margins with frozen-section analysis and trephine drill extraction technique: a preliminary study. Head & Neck, 32(11), 1473–1478.CrossRef Wysluch, A., Stricker, I., Hölzle, F., Wolff, K. D., & Maurer, P. (2010). Intraoperative evaluation of bony margins with frozen-section analysis and trephine drill extraction technique: a preliminary study. Head & Neck, 32(11), 1473–1478.CrossRef
15.
Zurück zum Zitat Kayamori, K., Sakamoto, K., Nakashima, T., Takayanagi, H., Morita, K., Omura, K., et al. (2010). Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. American Journal of Pathology, 176(2), 968–980.PubMedCrossRef Kayamori, K., Sakamoto, K., Nakashima, T., Takayanagi, H., Morita, K., Omura, K., et al. (2010). Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. American Journal of Pathology, 176(2), 968–980.PubMedCrossRef
16.
Zurück zum Zitat Martin, C. K., Werbeck, J. L., Thudi, N. K., Lanigan, L. G., Wolfe, T. D., Toribio, R. E., et al. (2010). Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Research, 70(21), 8607–8616.PubMedCrossRef Martin, C. K., Werbeck, J. L., Thudi, N. K., Lanigan, L. G., Wolfe, T. D., Toribio, R. E., et al. (2010). Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Research, 70(21), 8607–8616.PubMedCrossRef
17.
Zurück zum Zitat Yavropoulou, M. P., & Yovos, J. G. (2008). Osteoclastogenesis–current knowledge and future perspectives. Journal of Musculoskeletal and Neuronal Interactions, 8(3), 204–216.PubMed Yavropoulou, M. P., & Yovos, J. G. (2008). Osteoclastogenesis–current knowledge and future perspectives. Journal of Musculoskeletal and Neuronal Interactions, 8(3), 204–216.PubMed
18.
Zurück zum Zitat Hadjidakis, D. J., & Androulakis, I. I. (2006). Bone remodeling. Annals of the New York Academy of Sciences, 1092, 385–396.PubMedCrossRef Hadjidakis, D. J., & Androulakis, I. I. (2006). Bone remodeling. Annals of the New York Academy of Sciences, 1092, 385–396.PubMedCrossRef
19.
Zurück zum Zitat Raggatt, L. J., & Partridge, N. C. (2010). Cellular and molecular mechanisms of bone remodeling. Journal of Biological Chemistry, 285(33), 25103–25108.PubMedCrossRef Raggatt, L. J., & Partridge, N. C. (2010). Cellular and molecular mechanisms of bone remodeling. Journal of Biological Chemistry, 285(33), 25103–25108.PubMedCrossRef
20.
Zurück zum Zitat Georges, S., Ruiz, Velasco, C., Trichet, V., Fortun, Y., Heymann, D., et al. (2009). Proteases and bone remodelling. Cytokine & Growth Factor Reviews, 20(1), 29–41.CrossRef Georges, S., Ruiz, Velasco, C., Trichet, V., Fortun, Y., Heymann, D., et al. (2009). Proteases and bone remodelling. Cytokine & Growth Factor Reviews, 20(1), 29–41.CrossRef
21.
Zurück zum Zitat Woodward, J. K., Holen, I., Coleman, R. E., & Buttle, D. J. (2007). The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer. Bone, 41(6), 912–927.PubMedCrossRef Woodward, J. K., Holen, I., Coleman, R. E., & Buttle, D. J. (2007). The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer. Bone, 41(6), 912–927.PubMedCrossRef
22.
23.
Zurück zum Zitat Kessenbrock, K., Plaks, V., & Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141(1), 52–67.PubMedCrossRef Kessenbrock, K., Plaks, V., & Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141(1), 52–67.PubMedCrossRef
24.
Zurück zum Zitat Erdem, N. F., Carlson, E. R., Gerard, D. A., & Ichiki, A. T. (2007). Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. Journal of Oral and Maxillofacial Surgery, 65(9), 1725–1733.PubMedCrossRef Erdem, N. F., Carlson, E. R., Gerard, D. A., & Ichiki, A. T. (2007). Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. Journal of Oral and Maxillofacial Surgery, 65(9), 1725–1733.PubMedCrossRef
25.
Zurück zum Zitat Chuang, H. C., Su, C. Y., Huang, H. Y., Huang, C. C., Chien, C. Y., Du, Y. Y., et al. (2008). Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma. Modern Pathology, 21(12), 1444–1450.PubMedCrossRef Chuang, H. C., Su, C. Y., Huang, H. Y., Huang, C. C., Chien, C. Y., Du, Y. Y., et al. (2008). Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma. Modern Pathology, 21(12), 1444–1450.PubMedCrossRef
26.
Zurück zum Zitat Thiolloy, S., Halpern, J., Holt, G. E., Schwartz, H. S., Mundy, G. R., Matrisian, L. M., et al. (2009). Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. Cancer Research, 69(16), 6747–6755.PubMedCrossRef Thiolloy, S., Halpern, J., Holt, G. E., Schwartz, H. S., Mundy, G. R., Matrisian, L. M., et al. (2009). Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. Cancer Research, 69(16), 6747–6755.PubMedCrossRef
27.
Zurück zum Zitat Lynch, C. C., Hikosaka, A., Acuff, H. B., Martin, M. D., Kawai, N., Singh, R. K., et al. (2005). MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell, 7(5), 485–496.PubMedCrossRef Lynch, C. C., Hikosaka, A., Acuff, H. B., Martin, M. D., Kawai, N., Singh, R. K., et al. (2005). MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell, 7(5), 485–496.PubMedCrossRef
28.
Zurück zum Zitat Goto, T., Yamaza, T., & Tanaka, T. (2003). Cathepsins in the osteoclast. Journal of Electron Microscopy, 52(6), 551–558.PubMedCrossRef Goto, T., Yamaza, T., & Tanaka, T. (2003). Cathepsins in the osteoclast. Journal of Electron Microscopy, 52(6), 551–558.PubMedCrossRef
29.
Zurück zum Zitat Kawamata, H., Nakashiro, K., Uchida, D., Harada, K., Yoshida, H., & Sato, M. (1997). Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. International Journal of Cancer, 70(1), 120–127.CrossRef Kawamata, H., Nakashiro, K., Uchida, D., Harada, K., Yoshida, H., & Sato, M. (1997). Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. International Journal of Cancer, 70(1), 120–127.CrossRef
30.
Zurück zum Zitat Henson, B., Li, F., Coatney, D. D., Carey, T. E., Mitra, R. S., Kirkwood, K. L., et al. (2007). An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. Journal of Oral Pathology & Medicine, 36(6), 363–370.CrossRef Henson, B., Li, F., Coatney, D. D., Carey, T. E., Mitra, R. S., Kirkwood, K. L., et al. (2007). An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. Journal of Oral Pathology & Medicine, 36(6), 363–370.CrossRef
31.
Zurück zum Zitat Kawasaki, G., Kato, Y., & Mizuno, A. (2002). Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 93(4), 446–454.PubMedCrossRef Kawasaki, G., Kato, Y., & Mizuno, A. (2002). Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 93(4), 446–454.PubMedCrossRef
32.
Zurück zum Zitat Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature, 423(6937), 337–342.PubMedCrossRef Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature, 423(6937), 337–342.PubMedCrossRef
33.
Zurück zum Zitat Datta, N. S., & Abou-Samra, A. B. (2009). PTH and PTHrP signaling in osteoblasts. Cellular Signalling, 21(8), 1245–1254.PubMedCrossRef Datta, N. S., & Abou-Samra, A. B. (2009). PTH and PTHrP signaling in osteoblasts. Cellular Signalling, 21(8), 1245–1254.PubMedCrossRef
34.
Zurück zum Zitat Dougall, W. C., & Chaisson, M. (2006). The RANK/RANKL/OPG triad in cancer-induced bone diseases. Cancer and Metastasis Reviews, 25(4), 541–549.PubMedCrossRef Dougall, W. C., & Chaisson, M. (2006). The RANK/RANKL/OPG triad in cancer-induced bone diseases. Cancer and Metastasis Reviews, 25(4), 541–549.PubMedCrossRef
35.
Zurück zum Zitat Cochran, D. L. (2008). Inflammation and bone loss in periodontal disease. Journal of Periodontology, 79(8 Suppl), 1569–1576.PubMedCrossRef Cochran, D. L. (2008). Inflammation and bone loss in periodontal disease. Journal of Periodontology, 79(8 Suppl), 1569–1576.PubMedCrossRef
36.
Zurück zum Zitat Ishikuro, M., Sakamoto, K., Kayamori, K., Akashi, T., Kanda, H., Izumo, T., et al. (2008). Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas. Bone, 43(3), 621–627.PubMedCrossRef Ishikuro, M., Sakamoto, K., Kayamori, K., Akashi, T., Kanda, H., Izumo, T., et al. (2008). Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas. Bone, 43(3), 621–627.PubMedCrossRef
37.
Zurück zum Zitat Tada, T., Jimi, E., Okamoto, M., Ozeki, S., & Okabe, K. (2005). Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts. International Journal of Cancer, 116(2), 253–262.CrossRef Tada, T., Jimi, E., Okamoto, M., Ozeki, S., & Okabe, K. (2005). Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts. International Journal of Cancer, 116(2), 253–262.CrossRef
38.
Zurück zum Zitat Nakashima, T., & Takayanagi, H. (2008). The dynamic interplay between osteoclasts and the immune system. Archives of Biochemistry and Biophysics, 473(2), 166–171.PubMedCrossRef Nakashima, T., & Takayanagi, H. (2008). The dynamic interplay between osteoclasts and the immune system. Archives of Biochemistry and Biophysics, 473(2), 166–171.PubMedCrossRef
39.
Zurück zum Zitat Bar-Shavit, Z. (2007). The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. Journal of Cellular Biochemistry, 102(5), 1130–1139.PubMedCrossRef Bar-Shavit, Z. (2007). The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. Journal of Cellular Biochemistry, 102(5), 1130–1139.PubMedCrossRef
40.
Zurück zum Zitat Dewhirst, F. E., Stashenko, P. P., Mole, J. E., & Tsurumachi, T. (1985). Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. Journal of Immunology, 135(4), 2562–2568. Dewhirst, F. E., Stashenko, P. P., Mole, J. E., & Tsurumachi, T. (1985). Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. Journal of Immunology, 135(4), 2562–2568.
41.
Zurück zum Zitat Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J., et al. (2006). Osteoimmunology: interplay between the immune system and bone metabolism. Annual Review of Immunology, 24, 33–63.PubMedCrossRef Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J., et al. (2006). Osteoimmunology: interplay between the immune system and bone metabolism. Annual Review of Immunology, 24, 33–63.PubMedCrossRef
42.
Zurück zum Zitat Okamoto, M., Hiura, K., Ohe, G., Ohba, Y., Terai, K., Oshikawa, T., et al. (2000). Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo. Cancer, 89(9), 1966–1975.PubMedCrossRef Okamoto, M., Hiura, K., Ohe, G., Ohba, Y., Terai, K., Oshikawa, T., et al. (2000). Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo. Cancer, 89(9), 1966–1975.PubMedCrossRef
43.
Zurück zum Zitat Shibahara, T., Nomura, T., Cui, N. H., & Noma, H. (2005). A study of osteoclast-related cytokines in mandibular invasion by squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, 34(7), 789–793.PubMedCrossRef Shibahara, T., Nomura, T., Cui, N. H., & Noma, H. (2005). A study of osteoclast-related cytokines in mandibular invasion by squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, 34(7), 789–793.PubMedCrossRef
44.
Zurück zum Zitat Van, Cann, E. M., de Slootweg, P. J., Wilde, P. C., Otte-Höller, I., Koole, R., et al. (2009). The prediction of mandibular invasion by squamous cell carcinomas with the expression of osteoclast-related cytokines in biopsy specimens. International Journal of Oral and Maxillofacial Surgery, 38(3), 279–284.CrossRef Van, Cann, E. M., de Slootweg, P. J., Wilde, P. C., Otte-Höller, I., Koole, R., et al. (2009). The prediction of mandibular invasion by squamous cell carcinomas with the expression of osteoclast-related cytokines in biopsy specimens. International Journal of Oral and Maxillofacial Surgery, 38(3), 279–284.CrossRef
45.
Zurück zum Zitat Tsuchimochi, M., Kameta, A., Sue, M., & Katagiri, M. (2005). Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma. Odontology, 93(1), 61–71.PubMedCrossRef Tsuchimochi, M., Kameta, A., Sue, M., & Katagiri, M. (2005). Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma. Odontology, 93(1), 61–71.PubMedCrossRef
46.
Zurück zum Zitat Deyama, Y., Tei, K., Yoshimura, Y., Izumiyama, Y., Takeyama, S., Hatta, M., et al. (2008). Oral squamous cell carcinomas stimulate osteoclast differentiation. Oncology Reports, 20(3), 663–668.PubMed Deyama, Y., Tei, K., Yoshimura, Y., Izumiyama, Y., Takeyama, S., Hatta, M., et al. (2008). Oral squamous cell carcinomas stimulate osteoclast differentiation. Oncology Reports, 20(3), 663–668.PubMed
47.
Zurück zum Zitat Yamada, T., Tsuda, M., Ohba, Y., Kawaguchi, H., Totsuka, Y., & Shindoh, M. (2008). PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. Biochemical and Biophysical Research Communications, 368(3), 575–581.PubMedCrossRef Yamada, T., Tsuda, M., Ohba, Y., Kawaguchi, H., Totsuka, Y., & Shindoh, M. (2008). PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. Biochemical and Biophysical Research Communications, 368(3), 575–581.PubMedCrossRef
48.
Zurück zum Zitat Takayama, Y., Mori, T., Nomura, T., Shibahara, T., & Sakamoto, M. (2010). Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma. International Journal of Oncology, 36(6), 1387–1394.PubMed Takayama, Y., Mori, T., Nomura, T., Shibahara, T., & Sakamoto, M. (2010). Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma. International Journal of Oncology, 36(6), 1387–1394.PubMed
49.
Zurück zum Zitat Gronthos, S., & Zannettino, A. C. (2007). The role of the chemokine CXCL12 in osteoclastogenesis. Trends in Endocrinology and Metabolism, 18(3), 108–113.PubMedCrossRef Gronthos, S., & Zannettino, A. C. (2007). The role of the chemokine CXCL12 in osteoclastogenesis. Trends in Endocrinology and Metabolism, 18(3), 108–113.PubMedCrossRef
50.
Zurück zum Zitat Bonfil, R. D., Chinni, S., Fridman, R., Kim, H. R., & Cher, M. L. (2007). Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis. Urologic Oncology, 25(5), 407–411.PubMed Bonfil, R. D., Chinni, S., Fridman, R., Kim, H. R., & Cher, M. L. (2007). Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis. Urologic Oncology, 25(5), 407–411.PubMed
51.
Zurück zum Zitat Tang, C. H., Chuang, J. Y., Fong, Y. C., Maa, M. C., Way, T. D., & Hung, C. H. (2008). Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis, 29(8), 1483–1492.PubMedCrossRef Tang, C. H., Chuang, J. Y., Fong, Y. C., Maa, M. C., Way, T. D., & Hung, C. H. (2008). Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis, 29(8), 1483–1492.PubMedCrossRef
52.
Zurück zum Zitat Pandruvada, S. N., Yuvaraj, S., Liu, X., Sundaram, K., Shanmugarajan, S., Ries, W. L., et al. (2010). Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. International Journal of Cancer, 126(10), 2319–2329. Pandruvada, S. N., Yuvaraj, S., Liu, X., Sundaram, K., Shanmugarajan, S., Ries, W. L., et al. (2010). Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. International Journal of Cancer, 126(10), 2319–2329.
53.
Zurück zum Zitat Matsuo, K., & Irie, N. (2008). Osteoclast-osteoblast communication. Archives of Biochemistry and Biophysics, 473(2), 201–209.PubMedCrossRef Matsuo, K., & Irie, N. (2008). Osteoclast-osteoblast communication. Archives of Biochemistry and Biophysics, 473(2), 201–209.PubMedCrossRef
54.
Zurück zum Zitat Huang, S. M., Li, J., & Harari, P. M. (2002). Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Molecular Cancer Therapeutics, 1(7), 507–514.PubMed Huang, S. M., Li, J., & Harari, P. M. (2002). Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Molecular Cancer Therapeutics, 1(7), 507–514.PubMed
55.
Zurück zum Zitat Prime, S. S., Eveson, J. W., Stone, A. M., Huntley, S. P., Davies, M., Paterson, I. C., et al. (2004). Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1. The Journal of Pathology, 203(4), 927–932.PubMedCrossRef Prime, S. S., Eveson, J. W., Stone, A. M., Huntley, S. P., Davies, M., Paterson, I. C., et al. (2004). Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1. The Journal of Pathology, 203(4), 927–932.PubMedCrossRef
56.
Zurück zum Zitat Shimo, T., Kubota, S., Goda, T., Yoshihama, Y., Kurio, N., Nishida, T., et al. (2008). Clinical significance and pathogenic function of connective tissue growth factor (CTGF/CCN2) in osteolytic mandibular squamous cell carcinoma. Anticancer Research, 28(4C), 2343–2348.PubMed Shimo, T., Kubota, S., Goda, T., Yoshihama, Y., Kurio, N., Nishida, T., et al. (2008). Clinical significance and pathogenic function of connective tissue growth factor (CTGF/CCN2) in osteolytic mandibular squamous cell carcinoma. Anticancer Research, 28(4C), 2343–2348.PubMed
57.
Zurück zum Zitat Van der Pluijm, G. (2011). Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone, 48(1), 37–43.PubMedCrossRef Van der Pluijm, G. (2011). Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone, 48(1), 37–43.PubMedCrossRef
58.
Zurück zum Zitat Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9(4), 265–273.PubMedCrossRef Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9(4), 265–273.PubMedCrossRef
59.
Zurück zum Zitat Sterling, J. A., Edwards, J. R., Martin, T. J., & Mundy, G. R. (2011). Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone, 48(1), 6–15.PubMedCrossRef Sterling, J. A., Edwards, J. R., Martin, T. J., & Mundy, G. R. (2011). Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone, 48(1), 6–15.PubMedCrossRef
60.
Zurück zum Zitat Chaffer, C. L., & Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science, 331(6024), 1559–1564.PubMedCrossRef Chaffer, C. L., & Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science, 331(6024), 1559–1564.PubMedCrossRef
61.
Zurück zum Zitat Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704–715.PubMedCrossRef Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704–715.PubMedCrossRef
62.
Zurück zum Zitat Davies, M., Prime, S. S., Stone, A. M., Huntley, S. P., Eveson, J. W., & Paterson, I. C. (2000). Endogenous TGF-beta1 inhibits the growth and metastatic dissemination of rat oral carcinoma cell lines but enhances local bone resorption. Journal of Oral Pathology & Medicine, 29(5), 232–240.CrossRef Davies, M., Prime, S. S., Stone, A. M., Huntley, S. P., Eveson, J. W., & Paterson, I. C. (2000). Endogenous TGF-beta1 inhibits the growth and metastatic dissemination of rat oral carcinoma cell lines but enhances local bone resorption. Journal of Oral Pathology & Medicine, 29(5), 232–240.CrossRef
63.
Zurück zum Zitat Qiao, B., Johnson, N. W., & Gao, J. (2010). Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and −9 expressions. International Journal of Oncology, 37(3), 663–668.PubMed Qiao, B., Johnson, N. W., & Gao, J. (2010). Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and −9 expressions. International Journal of Oncology, 37(3), 663–668.PubMed
64.
Zurück zum Zitat Zhau, H. E., Odero-Marah, V., Lue, H. W., Nomura, T., Wang, R., Chu, G., et al. (2008). Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clinical & Experimental Metastasis, 25(6), 601–610.CrossRef Zhau, H. E., Odero-Marah, V., Lue, H. W., Nomura, T., Wang, R., Chu, G., et al. (2008). Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clinical & Experimental Metastasis, 25(6), 601–610.CrossRef
65.
Zurück zum Zitat Odero-Marah, V. A., Wang, R., Chu, G., Zayzafoon, M., Xu, J., Shi, C., et al. (2008). Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Research, 18(8), 858–870.PubMedCrossRef Odero-Marah, V. A., Wang, R., Chu, G., Zayzafoon, M., Xu, J., Shi, C., et al. (2008). Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Research, 18(8), 858–870.PubMedCrossRef
66.
Zurück zum Zitat He, H., Yang, X., Davidson, A. J., Wu, D., Marshall, F. F., Chung, L. W., et al. (2010). Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis. Prostate, 70(5), 518–528.PubMed He, H., Yang, X., Davidson, A. J., Wu, D., Marshall, F. F., Chung, L. W., et al. (2010). Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis. Prostate, 70(5), 518–528.PubMed
67.
Zurück zum Zitat Thompson, E. W., & Williams, E. D. (2008). EMT and MET in carcinoma–clinical observations, regulatory pathways and new models. Clinical & Experimental Metastasis, 25(6), 591–592.CrossRef Thompson, E. W., & Williams, E. D. (2008). EMT and MET in carcinoma–clinical observations, regulatory pathways and new models. Clinical & Experimental Metastasis, 25(6), 591–592.CrossRef
68.
Zurück zum Zitat Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Research, 68(10), 3645–3654.PubMedCrossRef Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Research, 68(10), 3645–3654.PubMedCrossRef
69.
Zurück zum Zitat Lo, J. F., Yu, C. C., Chiou, S. H., Huang, C. Y., Jan, C. I., Lin, S. C., et al. (2011). The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Research, 71(5), 1912–1923.PubMedCrossRef Lo, J. F., Yu, C. C., Chiou, S. H., Huang, C. Y., Jan, C. I., Lin, S. C., et al. (2011). The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Research, 71(5), 1912–1923.PubMedCrossRef
70.
Zurück zum Zitat Sethi, S., Macoska, J., Chen, W., & Sarkar, F. H. (2010). Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. American Journal of Translational Resreach, 3(1), 90–99. Sethi, S., Macoska, J., Chen, W., & Sarkar, F. H. (2010). Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. American Journal of Translational Resreach, 3(1), 90–99.
71.
Zurück zum Zitat Lo, W. L., Yu, C. C., Chiou, G. Y., Chen, Y. W., Huang, P. I., Chien, C. S., et al. (2011). MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. The Journal of Pathology, 223(4), 482–495.PubMedCrossRef Lo, W. L., Yu, C. C., Chiou, G. Y., Chen, Y. W., Huang, P. I., Chien, C. S., et al. (2011). MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. The Journal of Pathology, 223(4), 482–495.PubMedCrossRef
72.
Zurück zum Zitat Pentenero, M., Cistaro, A., Brusa, M., Ferraris, M. M., Pezzuto, C., Carnino, R., et al. (2008). Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma. Head & Neck, 30(11), 1488–1496.CrossRef Pentenero, M., Cistaro, A., Brusa, M., Ferraris, M. M., Pezzuto, C., Carnino, R., et al. (2008). Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma. Head & Neck, 30(11), 1488–1496.CrossRef
73.
Zurück zum Zitat Vidiri, A., Guerrisi, A., Pellini, R., Manciocco, V., Covello, R., Mattioni, O., et al. (2010). Multi-detector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the evaluation of the mandibular invasion by squamous cell carcinomas (SCC) of the oral cavity. Correlation with pathological data. Journal of Experimental & Clinical Cancer Research, 17, 29–73. Vidiri, A., Guerrisi, A., Pellini, R., Manciocco, V., Covello, R., Mattioni, O., et al. (2010). Multi-detector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the evaluation of the mandibular invasion by squamous cell carcinomas (SCC) of the oral cavity. Correlation with pathological data. Journal of Experimental & Clinical Cancer Research, 17, 29–73.
74.
Zurück zum Zitat Abd El-Hafez, Y. G., Chen, C. C., Ng, S. H., Lin, C. Y., Wang, H. M., Chan, S. C., et al. (2011). Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncology, 47(4), 288–295.PubMedCrossRef Abd El-Hafez, Y. G., Chen, C. C., Ng, S. H., Lin, C. Y., Wang, H. M., Chan, S. C., et al. (2011). Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncology, 47(4), 288–295.PubMedCrossRef
75.
Zurück zum Zitat Van, Cann, E. M., Koole, R., Oyen, W. J., de Rooy, J. W., de Wilde, P. C., et al. (2008). Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm. International Journal of Oral and Maxillofacial Surgery, 37(6), 535–541.CrossRef Van, Cann, E. M., Koole, R., Oyen, W. J., de Rooy, J. W., de Wilde, P. C., et al. (2008). Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm. International Journal of Oral and Maxillofacial Surgery, 37(6), 535–541.CrossRef
76.
Zurück zum Zitat Ayad, T., Guertin, L., Soulières, D., Belair, M., Temam, S., & Nguyen-Tân, P. F. (2009). Controversies in the management of retromolar trigone carcinoma. Head & Neck, 31(3), 398–405.CrossRef Ayad, T., Guertin, L., Soulières, D., Belair, M., Temam, S., & Nguyen-Tân, P. F. (2009). Controversies in the management of retromolar trigone carcinoma. Head & Neck, 31(3), 398–405.CrossRef
77.
Zurück zum Zitat Guerra, M. F., Campo, F. J., Gías, L. N., & Pérez, J. S. (2003). Rim versus sagittal mandibulectomy for the treatment of squamous cell carcinoma: two types of mandibular preservation. Head & Neck, 25(12), 982–989.CrossRef Guerra, M. F., Campo, F. J., Gías, L. N., & Pérez, J. S. (2003). Rim versus sagittal mandibulectomy for the treatment of squamous cell carcinoma: two types of mandibular preservation. Head & Neck, 25(12), 982–989.CrossRef
78.
Zurück zum Zitat Scully, C., & Bagan, J. (2009). Oral squamous cell carcinoma overview. Oral Oncology, 45(4–5), 301–308.PubMedCrossRef Scully, C., & Bagan, J. (2009). Oral squamous cell carcinoma overview. Oral Oncology, 45(4–5), 301–308.PubMedCrossRef
79.
Zurück zum Zitat Do, L., Syed, N., Puthawala, A., Azawi, S., Williams, R., & Vora, N. (2010). Prognostic significance of bone or cartilage invasion of locally advanced head and neck cancers. American Journal of Clinical Oncology, 33(6), 591–594.PubMedCrossRef Do, L., Syed, N., Puthawala, A., Azawi, S., Williams, R., & Vora, N. (2010). Prognostic significance of bone or cartilage invasion of locally advanced head and neck cancers. American Journal of Clinical Oncology, 33(6), 591–594.PubMedCrossRef
80.
Zurück zum Zitat Zhao, L., Guo, Q. L., You, Q. D., Wu, Z. Q., & Gu, H. Y. (2004). Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biological and Pharmaceutical Bulletin, 27(7), 998–1003.PubMedCrossRef Zhao, L., Guo, Q. L., You, Q. D., Wu, Z. Q., & Gu, H. Y. (2004). Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biological and Pharmaceutical Bulletin, 27(7), 998–1003.PubMedCrossRef
81.
Zurück zum Zitat Kasibhatla, S., Jessen, K. A., Maliartchouk, S., Wang, J. Y., English, N. M., Drewe, J., et al. (2005). A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proceedings of the National Academic of Science of the USA, 102(34), 12095–12100.CrossRef Kasibhatla, S., Jessen, K. A., Maliartchouk, S., Wang, J. Y., English, N. M., Drewe, J., et al. (2005). A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proceedings of the National Academic of Science of the USA, 102(34), 12095–12100.CrossRef
82.
Zurück zum Zitat Oh, H. M., Kwon, B. M., Baek, N. I., Kim, S. H., Lee, J. H., Eun, J. S., et al. (2006). Inhibitory activity of 6-O-angeloylprenolin from Centipeda minima on farnesyl protein transferase. Archives of Pharmacal Research, 29(1), 64–66.PubMedCrossRef Oh, H. M., Kwon, B. M., Baek, N. I., Kim, S. H., Lee, J. H., Eun, J. S., et al. (2006). Inhibitory activity of 6-O-angeloylprenolin from Centipeda minima on farnesyl protein transferase. Archives of Pharmacal Research, 29(1), 64–66.PubMedCrossRef
83.
Zurück zum Zitat Taylor, R. S., & Towers, G. H. (1998). Antibacterial constituents of the Nepalese medicinal herb, Centipeda minima. Phytochemistry, 47(4), 631–634.PubMedCrossRef Taylor, R. S., & Towers, G. H. (1998). Antibacterial constituents of the Nepalese medicinal herb, Centipeda minima. Phytochemistry, 47(4), 631–634.PubMedCrossRef
84.
Zurück zum Zitat Xu, X., Liu, Y., Wang, L., He, J., Zhang, H., Chen, X., et al. (2009). Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells. International Journal of Dermatology, 48(2), 186–192.PubMedCrossRef Xu, X., Liu, Y., Wang, L., He, J., Zhang, H., Chen, X., et al. (2009). Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells. International Journal of Dermatology, 48(2), 186–192.PubMedCrossRef
85.
Zurück zum Zitat Yan, F., Wang, M., Chen, H., Su, J., Wang, X., Wang, F., et al. (2011). Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells. European Journal of Pharmacology, 652(1–3), 23–32.PubMedCrossRef Yan, F., Wang, M., Chen, H., Su, J., Wang, X., Wang, F., et al. (2011). Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells. European Journal of Pharmacology, 652(1–3), 23–32.PubMedCrossRef
86.
Zurück zum Zitat Ding, L. F., Liu, Y., Liang, H. X., Liu, D. P., Zhou, G. B., & Cheng, Y. X. (2009). Two new terpene glucosides and antitumour agents from Centipeda minima. Journal of Asian Natural Products Research, 11(8), 732–736.PubMedCrossRef Ding, L. F., Liu, Y., Liang, H. X., Liu, D. P., Zhou, G. B., & Cheng, Y. X. (2009). Two new terpene glucosides and antitumour agents from Centipeda minima. Journal of Asian Natural Products Research, 11(8), 732–736.PubMedCrossRef
87.
Zurück zum Zitat Changlong, L., Hezhen, W., Yongping, H., Yanfang, Y., Yanwen, L., & Jianwen, L. (2008). 6-O-Angeloylenolin induces apoptosis through a mitochondrial/caspase and NF-kappaB pathway in human leukemia HL60 cells. Biomedicine and Pharmacotherapy, 62(6), 401–409.CrossRef Changlong, L., Hezhen, W., Yongping, H., Yanfang, Y., Yanwen, L., & Jianwen, L. (2008). 6-O-Angeloylenolin induces apoptosis through a mitochondrial/caspase and NF-kappaB pathway in human leukemia HL60 cells. Biomedicine and Pharmacotherapy, 62(6), 401–409.CrossRef
88.
Zurück zum Zitat Liu, Y., Chen, X. Q., Liang, H. X., Zhang, F. X., Zhang, B., Jin, J., et al. (2011). Small compound 6-O-Angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma. PLoS One, 6(7), e21930.PubMedCrossRef Liu, Y., Chen, X. Q., Liang, H. X., Zhang, F. X., Zhang, B., Jin, J., et al. (2011). Small compound 6-O-Angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma. PLoS One, 6(7), e21930.PubMedCrossRef
89.
Zurück zum Zitat Ziober, B. L., Mauk, M. G., Falls, E. M., Chen, Z., Ziober, A. F., & Bau, H. H. (2008). Lab-on-a-chip for oral cancer screening and diagnosis. Head & Neck, 30(1), 111–121.CrossRef Ziober, B. L., Mauk, M. G., Falls, E. M., Chen, Z., Ziober, A. F., & Bau, H. H. (2008). Lab-on-a-chip for oral cancer screening and diagnosis. Head & Neck, 30(1), 111–121.CrossRef
90.
Zurück zum Zitat Santini, D., Galluzzo, S., Zoccoli, A., Pantano, F., Fratto, M. E., Vincenzi, B., et al. (2010). New molecular targets in bone metastases. Cancer Treatment Reviews, 36(Suppl 3), S6–S10.PubMedCrossRef Santini, D., Galluzzo, S., Zoccoli, A., Pantano, F., Fratto, M. E., Vincenzi, B., et al. (2010). New molecular targets in bone metastases. Cancer Treatment Reviews, 36(Suppl 3), S6–S10.PubMedCrossRef
91.
Zurück zum Zitat Lee, R. J., Saylor, P. J., & Smith, M. R. (2011). Treatment and prevention of bone complications from prostate cancer. Bone, 48(1), 88–95.PubMedCrossRef Lee, R. J., Saylor, P. J., & Smith, M. R. (2011). Treatment and prevention of bone complications from prostate cancer. Bone, 48(1), 88–95.PubMedCrossRef
92.
Zurück zum Zitat Castellano, D., Sepulveda, J. M., García-Escobar, I., Rodriguez-Antolín, A., Sundlöv, A., & Cortes-Funes, H. (2011). The role of RANK-ligand inhibition in cancer: the story of denosumab. The Oncologist, 16(2), 136–145.PubMedCrossRef Castellano, D., Sepulveda, J. M., García-Escobar, I., Rodriguez-Antolín, A., Sundlöv, A., & Cortes-Funes, H. (2011). The role of RANK-ligand inhibition in cancer: the story of denosumab. The Oncologist, 16(2), 136–145.PubMedCrossRef
93.
Zurück zum Zitat Body, J. J., Greipp, P., Coleman, R. E., Facon, T., Geurs, F., Fermand, J. P., et al. (2003). A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer, 97(3 Suppl), 887–892.PubMedCrossRef Body, J. J., Greipp, P., Coleman, R. E., Facon, T., Geurs, F., Fermand, J. P., et al. (2003). A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer, 97(3 Suppl), 887–892.PubMedCrossRef
94.
Zurück zum Zitat Shin, M., Matsuo, K., Tada, T., Fukushima, H., Furuta, H., Ozeki, S., et al. (2011). The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis (in press) Shin, M., Matsuo, K., Tada, T., Fukushima, H., Furuta, H., Ozeki, S., et al. (2011). The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis (in press)
Metadaten
Titel
Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms
verfasst von
Jingjing Quan
Newell W. Johnson
Guangbiao Zhou
Peter G. Parsons
Glen M. Boyle
Jin Gao
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Cancer and Metastasis Reviews / Ausgabe 1-2/2012
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-011-9335-7

Weitere Artikel der Ausgabe 1-2/2012

Cancer and Metastasis Reviews 1-2/2012 Zur Ausgabe

NON-THEMATIC REVIEW

Bee venom in cancer therapy

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.